Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis.

Alice LaffiF SpadaV BagnardiS FrassoniE PisaM RubinoM BarberisN Fazio

Published in: Journal of endocrinological investigation (2021)

Our findings suggested that Ki-67 cutoff, functional imaging and the timing to NET G3 diagnosis may help clinicians in more accurate selection of NET G3 management. Prospective studies are needed.

Keyphrases

neuroendocrine tumors
high resolution
palliative care
neoadjuvant chemotherapy
case control
squamous cell carcinoma
mass spectrometry
fluorescence imaging
photodynamic therapy
rectal cancer